Lexicon Pharmaceuticals Inc Financial Flexibility Index
Lexicon Pharmaceuticals Inc financial flexibility index. Lexicon Pharmaceuticals Inc (LXRX) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of $-14.73 Million (operating CF $-14.73 Million minus capex $0.00) represents 0% of total liabilities ($65.96 Million). See Lexicon Pharmaceuticals Inc (LXRX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lexicon Pharmaceuticals Inc (1999–2025)
Financial flexibility index of Lexicon Pharmaceuticals Inc from 1999 to 2025. Historical Financial Flexibility Index trend for Lexicon Pharmaceuticals Inc across 27 annual periods. Check how high is Lexicon Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Lexicon Pharmaceuticals Inc Financial Flexibility Index by Year (1999–2025)
Lexicon Pharmaceuticals Inc financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Lexicon Pharmaceuticals Inc. For the full cash flow conversion analysis, see LXRX cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.88x | $-67.85 Million | $-67.85 Million | $77.45 Million | ▲ +24.9% |
| 2024 | -1.17x | $-177.75 Million | $-178.78 Million | $152.47 Million | ▲ +1.6% |
| 2023 | -1.18x | $-161.43 Million | $-161.90 Million | $136.32 Million | ▼ -4.4% |
| 2022 | -1.13x | $-87.53 Million | $-88.85 Million | $77.17 Million | ▲ +69.2% |
| 2021 | -3.68x | $-85.80 Million | $-87.02 Million | $23.31 Million | ▼ -22.1% |
| 2020 | -3.01x | $-142.88 Million | $-142.97 Million | $47.42 Million | ▼ -895.5% |
| 2019 | 0.38x | $113.88 Million | $113.81 Million | $300.61 Million | ▲ +179.2% |
| 2018 | -0.48x | $-148.51 Million | $-148.61 Million | $310.54 Million | ▲ +0.7% |
| 2017 | -0.48x | $-185.17 Million | $-185.39 Million | $384.44 Million | ▲ +12.6% |
| 2016 | -0.55x | $-175.40 Million | $-175.63 Million | $318.22 Million | ▼ -209.5% |
| 2015 | 0.50x | $185.69 Million | $184.78 Million | $368.98 Million | ▲ +224.8% |
| 2014 | -0.40x | $-75.54 Million | $-75.62 Million | $187.36 Million | ▲ +53.1% |
| 2013 | -0.86x | $-89.36 Million | $-91.08 Million | $104.00 Million | ▲ +3.9% |
| 2012 | -0.89x | $-93.97 Million | $-94.46 Million | $105.10 Million | ▼ -37.0% |
| 2011 | -0.65x | $-86.73 Million | $-87.94 Million | $132.94 Million | ▲ +3.7% |
| 2010 | -0.68x | $-81.24 Million | $-82.37 Million | $119.86 Million | ▲ +27.9% |
| 2009 | -0.94x | $-88.65 Million | $-89.02 Million | $94.26 Million | ▲ +33.9% |
| 2008 | -1.42x | $-93.41 Million | $-95.60 Million | $65.68 Million | ▼ -62.5% |
| 2007 | -0.88x | $-72.42 Million | $-74.32 Million | $82.72 Million | ▼ -72.0% |
| 2006 | -0.51x | $-53.33 Million | $-56.91 Million | $104.77 Million | ▼ -294.9% |
| 2005 | 0.26x | $34.72 Million | $23.44 Million | $132.91 Million | ▲ +177.6% |
| 2004 | -0.34x | $-30.45 Million | $-42.26 Million | $90.39 Million | ▼ -1274.2% |
| 2003 | -0.02x | $-2.89 Million | $-7.72 Million | $117.98 Million | ▲ +91.3% |
| 2002 | -0.28x | $-9.03 Million | $-28.79 Million | $31.87 Million | ▼ -35.5% |
| 2001 | -0.21x | $-4.52 Million | $-17.99 Million | $21.62 Million | ▼ -144.0% |
| 2000 | 0.48x | $6.21 Million | $-1.50 Million | $13.06 Million | ▲ +221.8% |
| 1999 | -0.39x | $-5.50 Million | $-9.60 Million | $14.10 Million | — |